Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
KBW's Michaud Explains What to Expect from a Pressured Q3 Bank Earnings Season

KBW's Michaud Explains What to Expect from a Pressured Q3 Bank Earnings Season

BeInCryptoBeInCrypto2026/10/09 02:21
Banks stay under pressure until the rate outlook settles, says Keefe, Bruyette Woods (KBW) CEO Tom Michaud. Bank stocks have given back 10 percentage points of relative performance since July 15, before third-quarter (Q3) bank earnings season. Yet he argues the selloff reflects rate nerves, not weakening fundamentals. Big-bank earnings start next week. Why Are Rates Outweighing Fundamentals This Q3 Bank Earnings Season? The 10-year Treasury yield touched about 5.35% this week, its highest since 2002. This comes as JPMorgan Chase, Goldman Sachs, Citigroup, and Wells Fargo report on October 13. Michaud said KBW, an investment bank focused on financial companies, used artificial intelligence (AI) to scan second-quarter earnings transcripts. Mentions of net interest margin, the gap between loan income and deposit costs, ran 60% above the prior three-year average. A regression analysis then found forecast changes in that margin correlated most closely with bank stock performance. Still, Michaud personally considers the rate worries overdone. Meanwhile, insider buying in financials has thinned, with the number of executives purchasing shares near a 23-year low. Michaud expects third-quarter investment banking profits to rise about 10% year over year, helped by a private equity backlog. The industry still feels like business is good. It cant be a record every quarter. Tom Michaud, president and CEO of KBW, on CNBCs Squawk on the Street. Could Bond Marks Slow Bank Buybacks? Michaud added that KBWs trading desk is hearing renewed concern about bond markets and interest rates, as in 2023. Unrealized bond losses equaled 19% of industry tangible capital, or equity minus goodwill, in 2023. Last quarter, they were 5%, he said. Those marks may slow buybacks at some banks. The largest banks have already optimized capital. In contrast, regional banks hold more excess and need not slow down. KBW modeled 200 banks through 2028. It projects tangible common equity, a core capital cushion, near 10% by then, versus 6.5% before the global financial crisis. However, Michaud expects one-off credit problems after years of near-zero credit costs. The question is whether they turn systemic. Return on tangible capital, KBWs best long-term fit for bank valuations, is improving and sits in the high teens. Read the article at BeInCrypto
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals

October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)

路透社•2026/10/09 04:26
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals

Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low

UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.

智通财经•2026/10/09 03:53